Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

MGN vs ABVE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

MGN Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–1 Matrix Metrics)

MGN Overall Winner 6-Pillar Tally: MGN 3 – 3 ABVE Matrix Metrics: MGN 7 – 1 ABVE

As of Nov 16, 2026, Megan Holdings Limited (MGN) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MGN carries a Unified Composite Score of 45.2/100 (HOLD) at $3.53 (N/M Forward P/E, -7.8% operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin).

  • Technical & Structure Timing Caution: MGN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 56.2); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About MGN vs ABVE
MGN NASDAQ Head-to-Head Winner
Megan Holdings Limited Ordinary Shares
Agricultural Prod-Livestock & Animal Specialties
$3.53
-1.94% 1D
Market Cap $58.4M
TTM Revenue $83M
Forward P/E N/M
Beta / 30D Vol 21.11β · 158% Vol
Unified Composite Score
45.2 / 100 HOLD
Tech 40.0 Fund 35.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (75.0% over 20 days), RSI 56
RSI-14: 56.2 · SMA20: $3.23 · SMA50: $2.91
ABVE NASDAQ
Above Food Ingredients Inc. Common Stock
Food And Kindred Products
$0.11
-80.57% 1D
Market Cap $30.0M
TTM Revenue $295M
Forward P/E N/M
Beta / 30D Vol 4.10β · 310% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 40.0 Fund 47.0 Flow 57.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -29.1%), weak momentum, RSI 28
RSI-14: 28.0 · SMA20: $0.55 · SMA50: $0.67

6-Pillar Scorecard Institutional Category Breakdown (MGN 3 – 3 ABVE)

Columns: Metric · MGN · ABVE
1. Valuation Multiples ABVE
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.7x 0.1x
2. Growth & Scale MGN
Revenue Growth (YoY) -8.4% -45.0%
Earnings Growth (YoY) -31.3% +0.0%
TTM Revenue (USD) $83M $295M
Market Cap $58.4M $30.0M
3. Profitability & Quality MGN
Gross Margin 0.8% -2.8%
Operating Margin -7.8% -23.2%
Net Profit Margin -8.3% -23.4%
Return on Equity (ROE) -12.6% 0.0%
4. Balance Sheet & Cash Flow MGN
Cash Generation (TTM) -$6.4M EBITDA -$40M EBITDA
Cash Flow Margin -7.7% EBITDA Mgn -13.7% EBITDA Mgn
Net Cash / Leverage $14.39 Book/Sh · -12.6% ROE 0.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning ABVE
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 148.3% (8th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ABVE
OpEx & R&D Intensity 8.6% of Rev ($7.1M) 20.4% of Rev ($60M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Engineering & Construction Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: MGN (7) vs ABVE (1)
Institutional Metric MGN ABVE Criterion Row Edge
Market Capitalization
Scale
$58.4M $30.0M Larger Scale MGN
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-8.4% -45.0% Higher Growth MGN
Operating Margin (TTM)
Profitability
-7.8% -23.2% Higher Margin MGN
Net Profit Margin
Profitability
-8.3% -23.4% Higher Margin MGN
Return on Equity (ROE)
Capital Efficiency
-12.6% 0.0% Higher ROE ABVE
52-Week Range Position
Momentum
68% ($0–$5) 0% ($0–$7) Stronger Trend MGN
Beta / 30D Volatility
Risk Regime
21.11β · 158% Vol 4.10β · 310% Vol Lower Realized Risk MGN
Unified Institutional Score
Composite Signal
45.2 / 100 (HOLD) 39.8 / 100 (SELL) Higher Composite MGN
Trailing 12M Revenue (USD)
Operating Scale
$83M $295M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
0.8% -2.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.7x EV/Rev N/M PEG · 0.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$6.4M EBITDA ($14.39 Book/Sh · -12.6% ROE) -$40M EBITDA (0.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon MGN +65.89 pp
MGN: -13.29% · ABVE: -79.18%
3M Horizon ABVE +2.4 pp
MGN: -93.83% · ABVE: -91.43%
6M Horizon MGN +2.88 pp
MGN: -92.79% · ABVE: -95.67%
1Y Horizon MGN +4.52 pp
MGN: -91.18% · ABVE: -95.7%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MGN vs ABVE. Trailing 12-month operating profitability (MGN -7.8% vs ABVE -23.2%) and valuation multiples (MGN N/M vs ABVE N/M Forward P/E) are benchmarked directly in Pillar 4 below.

MGN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$83M
Gross Margin0.8%
Op. Margin-7.8%
ROE / Fwd P/E-12.6% · N/M
ABVE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$295M
Gross Margin-2.8%
Op. Margin-23.2%
ROE / Fwd P/E0.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
MGN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact MGN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABVE UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 148.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ABVE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
MGN Moat Profile Cyclical / Execution-Driven Positioning
Engineering & Construction Operator
Competes within the Engineering & Construction value chain with $58.4M market capitalization and -7.8% operating margin.
OpEx & R&D Reinvestment 8.6% of Rev ($7.1M)
90D Engineering Disclosures 0 Published
ABVE Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $30.0M market capitalization and -23.2% operating margin.
OpEx & R&D Reinvestment 20.4% of Rev ($60M)
90D Engineering Disclosures 0 Published

Investor FAQ MGN vs ABVE Key Questions & Quantitative Answers

As of Nov 16, 2026, Megan Holdings Limited (MGN) is the stronger overall head-to-head candidate over Above Food Ingredients Inc. (ABVE) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). MGN carries a Unified Composite Score of 45.2/100 (HOLD) at $3.53 (N/M Forward P/E, -7.8% operating margin), whereas ABVE carries 39.8/100 (SELL) at $0.11 (N/M Forward P/E, -23.2% operating margin). Technical & Structure Timing Caution: MGN trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 56.2); meanwhile ABVE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

MGN leads the Growth & Scale pillar: MGN posts -8.4% YoY revenue growth and -31.3% YoY earnings growth on $83M TTM revenue (0.8% gross margin, -7.8% operating margin), compared with ABVE at -45.0% YoY revenue growth and +0.0% YoY earnings growth on $295M TTM revenue (-2.8% gross margin, -23.2% operating margin). On trailing 12-month operating scale, MGN generates $83M in USD-normalized revenue versus $295M for ABVE. In operating R&D and SG&A reinvestment, MGN deploys 8.6% of Rev ($7.1M) (0 90-day corporate R&D disclosures) versus 20.4% of Rev ($60M) (0 disclosures) for ABVE.

ABVE screens cheaper on headline valuation multiples. MGN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-7.7% EBITDA margin), whereas ABVE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-13.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against MGN (-12.6% ROE) versus ABVE (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, MGN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (21.11β · 158% Vol realized risk). By comparison, ABVE carries 148.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.10β · 310% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.